Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

337

HTML

3382

Figures (1-2)

115

Tables (1-1)

122

Sum=3956

Jan 14, 2013 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 14, 2013; 19(2): 241-248
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.241

Figure 1 Effect of atorvastatin on hepatic stellate cells proliferation. PDGF: Platelet derived growth factor.

Figure 2 Atorvastatin effect on the expression of smooth muscle actin. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; SMA: Smooth muscle actin.

Citation: Shirin H, Sharvit E, Aeed H, Gavish D, Bruck R. Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats. World J Gastroenterol 2013; 19(2): 241-248
URL: https://www.wjgnet.com/1007-9327/full/v19/i2/241.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i2.241